Santen Pharmaceutical Co., Ltd. held its 96th Annual General Meeting of Shareholders on June 25, 2008. The Meeting started at 10:00 a.m. and ended at 11:13 a.m. The number of shareholders attended was 168.
- Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 96th Business Term (April 1, 2007 to March 31, 2008)
- Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 96th Business Term (April 1, 2007 to March 31, 2008)
|Questions||Questions regarding oversea business, new drug candidates, manufacturing issues and medium-term management plan were answered.|
|Matters resolved||Five items of business as described below were all resolved.
|Questions||Question regarding Proposal 2 (Appointment of Directors) and Proposal 4 (Issuance of the Rights to Subscribe for New Shares as Stock Option for the Directors) were answered.|